1. Home
  2. AMPH vs LOB Comparison

AMPH vs LOB Comparison

Compare AMPH & LOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • LOB
  • Stock Information
  • Founded
  • AMPH 1996
  • LOB 2008
  • Country
  • AMPH United States
  • LOB United States
  • Employees
  • AMPH N/A
  • LOB N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • LOB Major Banks
  • Sector
  • AMPH Health Care
  • LOB Finance
  • Exchange
  • AMPH Nasdaq
  • LOB Nasdaq
  • Market Cap
  • AMPH 2.5B
  • LOB 2.2B
  • IPO Year
  • AMPH 2014
  • LOB 2015
  • Fundamental
  • Price
  • AMPH $44.55
  • LOB $47.38
  • Analyst Decision
  • AMPH Buy
  • LOB Buy
  • Analyst Count
  • AMPH 4
  • LOB 6
  • Target Price
  • AMPH $63.00
  • LOB $45.67
  • AVG Volume (30 Days)
  • AMPH 404.9K
  • LOB 249.2K
  • Earning Date
  • AMPH 11-06-2024
  • LOB 10-23-2024
  • Dividend Yield
  • AMPH N/A
  • LOB 0.25%
  • EPS Growth
  • AMPH 17.38
  • LOB 39.66
  • EPS
  • AMPH 3.01
  • LOB 1.84
  • Revenue
  • AMPH $723,549,000.00
  • LOB $405,743,000.00
  • Revenue This Year
  • AMPH $17.23
  • LOB N/A
  • Revenue Next Year
  • AMPH $10.25
  • LOB $16.54
  • P/E Ratio
  • AMPH $14.78
  • LOB $25.73
  • Revenue Growth
  • AMPH 20.33
  • LOB 9.13
  • 52 Week Low
  • AMPH $36.56
  • LOB $31.03
  • 52 Week High
  • AMPH $65.92
  • LOB $50.57
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 38.65
  • LOB 54.80
  • Support Level
  • AMPH $43.09
  • LOB $45.05
  • Resistance Level
  • AMPH $49.53
  • LOB $49.19
  • Average True Range (ATR)
  • AMPH 1.76
  • LOB 1.67
  • MACD
  • AMPH -0.62
  • LOB 0.18
  • Stochastic Oscillator
  • AMPH 13.43
  • LOB 71.97

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

Share on Social Networks: